HUM-MOLGEN events: RECOMBINANT ANTIBODIES

HUM-MOLGEN -> Events -> Meetings and Conferences

November 29, 2001

Cambridge Healthtech Institute, University Park Hotel @ M.I.T. - Cambridge, Massachusetts
April 24-25, 2002

The pipeline of therapeutic antibodies has been growing steadily, building on successful clinical trials particularly in cancer. This growth will certainly accelerate, as genomic companies with many novel targets seek to employ antibodies to modulate these targets. In addition, studies employing antibodies, or antibody mimics, are being ramped up as part of the explosive growth of proteomics. All of these trends place a tremendous emphasis on the development of new approaches for faster antibody development, improved methods of selection and optimization, alternatives for production, and evaluation for novel applications. This conference will provide you will key updates on important developments in each of these areas.

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

Fax or e-mail your submission to:

Elizabeth Lamb
Conference Director
Cambridge Healthtech Institute
Fax: 207-493-4573, E-mail: elamb@healthtech.com

Deadline for Abstracts:

March 22, 2002

Registration:

http://www.healthtech.com/2002/pgd/reg.htm

E-mail:

fvargus@healthtech.com

Posted by:

Frederick Vargus